PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 497.00
+3.00 (0.61%)
Feb 17, 2026, 10:53 AM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 2.01 billion as of February 13, 2026. Its market cap has increased by 51.34% in one year.
Market Cap
2.01B
Enterprise Value
1.30B
Revenue
1.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
497.00
Market Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 2.01B, a decrease of -75.04%. That is a compound annual growth rate of -13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.90B | -3.51% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soiken Holdings | 6.83B |
| Noile-Immune Biotech | 6.67B |
| Carna Biosciences | 6.43B |
| TMS Co., Ltd. | 6.23B |
| Kohjin Bio | 6.13B |
| D. Western Therapeutics Institute | 5.48B |
| Transgenic Group | 5.03B |
| Ribomic | 4.45B |